- Home
- EVAX vs INBS Comparison
EVAX vs INBS Comparison
Compare EVAX & INBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVAX
- INBS
- Stock Information
- Founded
- EVAX 2008
- INBS 2016
- Country
- EVAX Denmark
- INBS United States
- Employees
- EVAX N/A
- INBS N/A
- Industry
- EVAX Biotechnology: Biological Products (No Diagnostic Substances)
- INBS Medical Specialities
- Sector
- EVAX Health Care
- INBS Health Care
- Exchange
- EVAX Nasdaq
- INBS Nasdaq
- Market Cap
- EVAX 16.3M
- INBS 16.4M
- IPO Year
- EVAX 2021
- INBS N/A
- Fundamental
- Price
- EVAX $1.79
- INBS $2.12
- Analyst Decision
- EVAX Strong Buy
- INBS
- Analyst Count
- EVAX 3
- INBS 0
- Target Price
- EVAX $33.33
- INBS N/A
- AVG Volume (30 Days)
- EVAX 211.9K
- INBS 259.7K
- Earning Date
- EVAX 03-26-2025
- INBS 05-07-2025
- Dividend Yield
- EVAX N/A
- INBS N/A
- EPS Growth
- EVAX N/A
- INBS N/A
- EPS
- EVAX N/A
- INBS N/A
- Revenue
- EVAX $3,295,000.00
- INBS $3,031,405.00
- Revenue This Year
- EVAX $9,039.73
- INBS $280.88
- Revenue Next Year
- EVAX $1.47
- INBS $126.26
- P/E Ratio
- EVAX N/A
- INBS N/A
- Revenue Growth
- EVAX N/A
- INBS 23.21
- 52 Week Low
- EVAX $1.70
- INBS $1.00
- 52 Week High
- EVAX $22.05
- INBS $4.64
- Technical
- Relative Strength Index (RSI)
- EVAX 35.07
- INBS 50.75
- Support Level
- EVAX $1.75
- INBS $2.04
- Resistance Level
- EVAX $1.99
- INBS $2.28
- Average True Range (ATR)
- EVAX 0.17
- INBS 0.22
- MACD
- EVAX 0.05
- INBS -0.03
- Stochastic Oscillator
- EVAX 10.70
- INBS 35.59
About EVAX Evaxion Biotech
Evaxion Biotech AS is a clinical-stage biotech company that aspires to the exploration of artificial intelligence, or AI, to develop immunotherapies with improved efficacy when compared to currently marketed products for patients with unmet medical needs. Its pipeline programs are derived from its proprietary AI platforms, PIONEER, EDEN, RAVEN, and ObsERV. The company is utilizing these AI platforms to build a drug development pipeline. Its product candidates are; EVX-01 and EVX-02, for the treatment of various cancers, and the third candidate is cancer immunotherapy, EVX-03, for the treatment of various cancers including non-small-cell-lung-cancer, or NSCLC, is in pre-clinical development.
About INBS Intelligent Bio Solutions Inc.
Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company business through two operating segments include Commercially available Intelligent Fingerprinting Products (IFPG or IFPG segment) and, Development Stage Biosensor Platform Technology (BPT segment).